These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8235704)
1. Axl, a novel receptor tyrosine kinase isolated from chronic myelogenous leukemia. Neubauer A; O'Bryan JP; Fiebeler A; Schmidt C; Huhn D; Liu ET Semin Hematol; 1993 Jul; 30(3 Suppl 3):34. PubMed ID: 8235704 [No Abstract] [Full Text] [Related]
2. Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid Leukemia. Ben-Batalla I; Erdmann R; Jørgensen H; Mitchell R; Ernst T; von Amsberg G; Schafhausen P; Velthaus JL; Rankin S; Clark RE; Koschmieder S; Schultze A; Mitra S; Vandenberghe P; Brümmendorf TH; Carmeliet P; Hochhaus A; Pantel K; Bokemeyer C; Helgason GV; Holyoake TL; Loges S Clin Cancer Res; 2017 May; 23(9):2289-2300. PubMed ID: 27856601 [No Abstract] [Full Text] [Related]
3. ZNF224 is a transcriptional repressor of AXL in chronic myeloid leukemia cells. Sodaro G; Blasio G; Fiorentino F; Auberger P; Costanzo P; Cesaro E Biochimie; 2018 Nov; 154():127-131. PubMed ID: 30176265 [TBL] [Abstract][Full Text] [Related]
4. Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin. Jin Y; Nie D; Li J; Du X; Lu Y; Li Y; Liu C; Zhou J; Pan J Clin Cancer Res; 2017 Jun; 23(11):2842-2855. PubMed ID: 27852702 [No Abstract] [Full Text] [Related]
8. Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death. Wang Y; Liu J; Wu Y; Luo W; Lin SH; Lin H; Hawk N; Sun T; Guo JQ; Estrov Z; Talpaz M; Champlin R; Arlinghaus RB Cancer Res; 2001 Jan; 61(1):138-44. PubMed ID: 11196151 [TBL] [Abstract][Full Text] [Related]
9. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p. Pini M; Gottardi E; Scaravaglio P; Giugliano E; Libener R; Baraldi A; Muzio A; Cornaglia E; Saglio G; Levis A Hematol J; 2002; 3(6):315-6. PubMed ID: 12522455 [No Abstract] [Full Text] [Related]
10. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Demiroglu A; Steer EJ; Heath C; Taylor K; Bentley M; Allen SL; Koduru P; Brody JP; Hawson G; Rodwell R; Doody ML; Carnicero F; Reiter A; Goldman JM; Melo JV; Cross NC Blood; 2001 Dec; 98(13):3778-83. PubMed ID: 11739186 [TBL] [Abstract][Full Text] [Related]
11. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. O'Donnell K; Harkes IC; Dougherty L; Wicks IP Am J Pathol; 1999 Apr; 154(4):1171-80. PubMed ID: 10233855 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of AXL kinase family in gastric cancer. Wu CW; Li AF; Chi CW; Lai CH; Huang CL; Lo SS; Lui WY; Lin WC Anticancer Res; 2002; 22(2B):1071-8. PubMed ID: 12168903 [TBL] [Abstract][Full Text] [Related]
13. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Neubauer A; Fiebeler A; Graham DK; O'Bryan JP; Schmidt CA; Barckow P; Serke S; Siegert W; Snodgrass HR; Huhn D Blood; 1994 Sep; 84(6):1931-41. PubMed ID: 7521695 [TBL] [Abstract][Full Text] [Related]
15. Internal tandem duplication in the juxtatransmembrane domain of the flt3 is not involved in blastic crisis of chronic myeloid leukemia. Iwai T; Yokota S; Nakao M; Kaneko H; Nakai H; Kashima K; Misawa S Leukemia; 1997 Nov; 11(11):1992-3. PubMed ID: 9369441 [No Abstract] [Full Text] [Related]
16. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. O'Bryan JP; Frye RA; Cogswell PC; Neubauer A; Kitch B; Prokop C; Espinosa R; Le Beau MM; Earp HS; Liu ET Mol Cell Biol; 1991 Oct; 11(10):5016-31. PubMed ID: 1656220 [TBL] [Abstract][Full Text] [Related]
17. Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells. Gioia R; Leroy C; Drullion C; Lagarde V; Etienne G; Dulucq S; Lippert E; Roche S; Mahon FX; Pasquet JM Blood; 2011 Aug; 118(8):2211-21. PubMed ID: 21730355 [TBL] [Abstract][Full Text] [Related]
18. Inverse regulation of bridging integrator 1 and BCR-ABL1 in chronic myeloid leukemia. Trino S; De Luca L; Simeon V; Laurenzana I; Morano A; Caivano A; La Rocca F; Pietrantuono G; Bianchino G; Grieco V; Signorino E; Fragasso A; Bochicchio MT; Venturi C; Rosti G; Martinelli G; Del Vecchio L; Cilloni D; Musto P Tumour Biol; 2016 Jan; 37(1):217-25. PubMed ID: 26194865 [TBL] [Abstract][Full Text] [Related]
19. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia. Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960 [No Abstract] [Full Text] [Related]
20. The human receptor tyrosine kinase Axl gene--promoter characterization and regulation of constitutive expression by Sp1, Sp3 and CpG methylation. Mudduluru G; Allgayer H Biosci Rep; 2008 Jun; 28(3):161-76. PubMed ID: 18522535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]